tiprankstipranks
Trending News
More News >
Autolus Therapeutics (AUTL)
:AUTL
US Market

Autolus Therapeutics (AUTL) Income Statement

Compare
820 Followers

Autolus Therapeutics Income Statement

Last quarter (Q3 2025), Autolus Therapeutics's total revenue was $21.19M, an increase of Infinity% from the same quarter last year. In Q3, Autolus Therapeutics's net income was $-79.12M. See Autolus Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 10.12M$ 1.70M$ 6.19M$ 1.51M$ 1.72M
Gross Profit
$ -130.90M$ 1.70M$ 6.19M$ 1.51M$ -133.17M
Operating Expenses
$ 110.53M$ 181.40M$ 149.09M$ 141.88M$ 169.96M
Depreciation and Amortization
$ 7.72M$ 6.57M$ 7.42M$ 8.46M$ 5.57M
EBITDA
$ -233.07M$ -156.77M$ -132.24M$ -132.47M$ -162.58M
Operating Income
$ -241.43M$ -179.70M$ -142.89M$ -140.37M$ -303.13M
Other Income/Expenses
$ 22.29M$ -28.70M$ -5.67M$ -1.66M$ 136.88M
Pretax Income
$ -219.13M$ -208.40M$ -148.57M$ -142.04M$ -166.26M
Net Income
$ -220.66M$ -208.38M$ -148.84M$ -142.10M$ -142.09M
Per Share Metrics
Basic EPS
$ -0.87$ -1.20$ -1.57$ -1.97$ -2.76
Diluted EPS
$ -0.87$ -1.20$ -1.57$ -1.97$ -2.76
Weighted Average Shares Outstanding
255.16M 173.94M 94.99M 72.08M 51.56M
Weighted Average Shares Outstanding (Diluted)
255.16M 173.94M 94.99M 72.08M 51.56M
Currency in USD

Autolus Therapeutics Earnings and Revenue History